Frazier Life Sciences Raises $1.3bn To Fund Start-Ups Through Value-Creating Data

Fund XII Eclipses Prior $987m VC Fund In 2022

 
• By Mandy Jackson
  
Frazier Life Sciences will put 40%-50% of Fund XII into company creation and 30% into series A rounds (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business